References
  1. Harris M, Clark J, Coote N, et al. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;356:1-23.
  2. World Health Organization. Pneumonia. WHO, 2015.
  3. J. Ciencewicki, S. Trivedi, S.R. Kleeberger. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol. 2008;122:456-470.
  4. D. Morris, M. Khurasany, T. Nguyen et al. “Glutathione and Infection,” Biochem Biopys Acta. 2013;1830:3329-3349.
  5. Muravlyova L, Luchankiy-Molotov V, Bakirova R, Klyuyev D, Demidchik L, Lee V. Characteristics of the oxidative stress in blood of patients in depence of community-acquired pneumonia severity. Open Access Maced J Med Sci. 2016;4:122-127.
  6. Principi N, Esposito S. Biomarkers in Pediatric Community-Acquired Pneumonia. Int J Mol Sci. 2017;18. pii: E447.
  7. Haq IJ, Battersby AC, Eastham K, McKean M. Community acquired pneumonia in children. BMJ. 2017;356: j686.
  8. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clinical Biochemistry 2014; 47:326–332.
  9. Erel, O. A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 2005;38:1103–1111.
  10. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85.
  11. Harma, M., Harma, M. and Erel, O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005;118:47–51.
  12. Eckerson HW, Romson J, Wyte C, La Du BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet. 1983;35:214-27.
  13. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196:143-51.
  14. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem. 1992;30:391-395.
  15. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
  16. O. Erel, Automated measurement of serum ferroxidase activity, Clin. Chem. 1998;44:2313–2319.
  17. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19:311-5.
  18. Esen R, Aslan M, Kucukoglu ME et al. Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis. Wien Klin Wochenschr. 2015;127:427-33.
  19. Stocker R, Keaney Jr F. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-478.
  20. Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol. 2006;71:551-64.
  21. Gulpamuk B, Tekin K, Sonmez K et al. The significance of thiol/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus. Scand J Clin Lab Invest. 2018;78:136-142.
  22. Kara SS, Erel O, Demirdag TB et al. Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis. Redox Rep. 2017;22:205-209.
  23. Aycicek A, Iscan A, Erel O, Akcali M, Selek S. Total Antioxidant/Oxidant Status in Meningism and Meningitis. Pediatr Neurol. 2006;35:382-6.
  24. Ozyazici S,Karateke F, Turan U et al. A Novel Oxidative Stress Mediator in Acute Appendicitis:Thiol/Disulphide Homeostasis Mediators Inflamm. 2016;2016:6761050.
  25. Karadag-Oncel E, Erel O, Ozsurekci Y et al. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever. Jpn J Infect Dis. 2014;67:22-26.
  26. Parlak SE, Alisik M, Hezer H, Karalezli A, Hasanoglu HC, Erel O. Evaluation of dynamic thiol/disulfide redox state in community-acquired pneumonia. Saudi Med J. 2018;39:495-499.
  27. Leelarungrayub J, Borisuthibandit T, Yankai A, Boontha K.Changes in oxidative stress from tracheal aspirates sampled during chest physical therapy in hospitalized intubated infant patients with pneumonia and secretion retention. Ther Clin Risk Manag. 2016;6:1377-1386.
  28. Chan B, Dodsworth N, Woodrow J, et al. Sitespecific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995;227:524–528.
  29. Cheng CW, Chien MH, Su SC, Yang SF. New markers in pneumonia. Clin Chim Acta. 2013;419:19-25.
  30. Grover H, Saini R, Bhardwaj P, Bhardwaj A. Acute-phase reactans. Journal of Oral Research and Review. 2016:8;31-35.
  31. Bolatkale M, Duger M, Ülfer G et al. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin. Am J Emerg Med. 2017;35:1121-1125.
  32. Yerlikaya FH, Kurban S, Mehmetoglu I et al. Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis. J Matern Fetal Neonatal Med. 2014;27:1723-1727.
  33. H.S. Park, S.R. Kim, Y.C. Lee. Impact of oxidative stress on lung diseases. Respirology. 2009;14:27-38.
  34. Trefler S, Rodríguez A, Martín-Loeches I et al. Oxidative stress in immunocompetent patients with severe community-acquired pneumonia. A pilot study. Med Intensiva. 2014;38:73-82.
  35. Katsoulis K, Kontakiotis T, Baltopoulos G, Kotsovili A, Legakis IN. Total antioxidant status and severity of communityacquired pneumonia: are they correlated? Respiration 2005;72:381-387.
  36. Van den Bruel A, Thompson MJ, Haj-Hassan T. et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systeMatic review. BMJ. 2011;8:d3082.
  37. Pohanka M. Role of oxidative stress in infectious diseases. A review. Folia Microbiol (Praha). 2013;58:503-513.
  38. Braun J, Dalhoff K, Lipp R et al. Myeloperoxidase, lactoferrin and elastase in bronchoalveolar lavage and plasma in pneumonia. Pneumologie. 1992;46:141-147.
  39. Cemek M, Caksen H, Bayiroğlu F, Cemek F, Dede S. Oxidative stress and enzymic-non-enzymic antioxidant responses in children with acute pneumonia. Cell Biochem Funct. 2006;24:269-273.
  40. Shepelenko AF, Khatskevich VL, Lishcheniuk OA, Korshunov GV, Dolmashkina MA. The role of humoral markers of inflammation activity in the evaluation of adequacy of antibacterial chemotherapy for community-acquired pneumonia. Voen Med Zh. 2005;326:25-30.